Clinical utility gene card for: Hereditary diffuse gastric cancer (HDGC)

European Journal of Human Genetics

Volumn 21, Issue 8, 2013, Pages 891-

  Oliveira, Carla ^a,b   Seruca, Raquel ^a,b   Hoogerbrugge, Nicoline ^c   Ligtenberg, Marjolijn ^c   Carneiro, Fátima ^a,b,d  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Universidade do Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN 1; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; CADHERIN; CDH1 PROTEIN, HUMAN;

ARTICLE; DIAGNOSTIC PROCEDURE; ETHNIC GROUP; FAMILY HISTORY; GENETIC ANALYSIS; GENETIC RISK; GENETIC SCREENING; GENOTYPING TECHNIQUE; HEREDITARY DIFFUSE GASTRIC CANCER; INDEL MUTATION; LIFESTYLE; MUTATIONAL ANALYSIS; NONSENSE MUTATION; PREDICTIVE VALUE; PRENATAL DIAGNOSIS; PREVALENCE; PREVENTION; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; STOMACH CANCER; STOP CODON; GENETICS; HUMAN; MUTATION; PROGNOSIS; SENSITIVITY AND SPECIFICITY; STOMACH TUMOR;

CADHERINS; GENETIC TESTING; HUMANS; MUTATION; PROGNOSIS; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS;

EID: 84880922499     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2012.247     Document Type: Article

References (18)

1. Oliveira C, Senz J, Kaurah P et al: Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet 2009; 18: 1545-1555
2. Corso G, Pedrazzani C, Pinheiro H et al: E-cadherin genetic screening and clinicopathologic characteristics of early onset gastric cancer. Eur J Cancer 2011; 47: 631-639
3. Kaurah P, MacMillan A, Boyd N et al: Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 2007; 297: 2360-2372
4. Suriano G, Oliveira C, Ferreira P et al: Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum Mol Genet 2003; 12: 575-582
5. Fitzgerald RC, Hardwick R, Huntsman D et al: International Gastric Cancer Linkage Consortium: Hereditary diffuse gastric cancer: Updated consensus guidelines for clinical management and directions for future research. J Med Genet 2010; 47: 436-444
6. Oliveira C, Seruca R, Carneiro F: Hereditary gastric cancer. Best Pract Res Clin Gastroenterol 2009; 23: 147-157
7. Pinheiro H, Bordeira-Carriço R, Seixas S et al: Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer. Hum Mol Genet 2010; 19: 943-952
8. Pharoah PD, Guilford P, Caldas C: International Gastric Cancer Linkage Consortium: Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001; 121: 1348-1353
9. Oliveira C, Moreira H, Seruca R, de Oliveira MC, Carneiro F: Role of pathology in the identification of hereditary diffuse gastric cancer: Report of a Portuguese family. Virchows Arch 2005; 446: 181-184
10. Barber ME, Save V, Carneiro F et al: Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. J Pathol 2008; 216: 286-294
11. Kluijt I, Sijmons RH, Hoogerbrugge N et al: Familial gastric cancer: Guidelines for diagnosis, treatment and periodic surveillance. Fam Cancer 2012; 11: 363-369
12. Kurian AW, Sigal BM, Plevritis SK: Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. J Clin Oncol 2010; 28: 222-231
13. Hoogerbrugge N, Kamm YJ, Bult P et al: The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited. Ann Oncol 2008; 19: 655-659
14. Kaurah P, Fitzgerald R, Dwerryhouse S, Huntsman DG: Pregnancy after prophylactic total gastrectomy. Fam Cancer 2010; 9: 331-334
15. Fitzgerald RC, Caldas C: Clinical implications of E-cadherin associated hereditary diffuse gastric cancer. Gut 2004; 53: 775-778
16. Huntsman DG, Carneiro F, Lewis FR et al: Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 2001; 344: 1904-1909
17. Carneiro F, Huntsman DG, Smyrk TC et al: Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 2004; 203: 681-687
18. Kluijt I, Siemerink EJ, Ausems MG et al: On behalf of the Dutch Working Group on Hereditary Gastric Cancer. CDH1-related hereditary diffuse gastric cancer syndrome: Clinical variations and implications for counseling. Int J Cancer 2011; 131: 367-376